ReviewJournal of clinical medicine2024

Dry Eye Para-Inflammation Management: Preclinical and Clinical Evidence on a Novel 0.2% Hyaluronic Acid-Based Tear Substitute with 0.001% Hydrocortisone Sodium Phosphate.

Anna Rita Blanco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.